Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

China Dongxiang (Group) Co ( ($HK:3818) ) just unveiled an announcement. China Dongxiang (Group) Co., Ltd. has warned that it expects to swing to a...

China Dongxiang Flags Swing to Loss on Market Volatility and FX Hit

Telsey Advisory analyst Joe Feldman maintained a Buy rating on Dollar General today and set a price target of $140.00. According to TipRanks, Feldm...

Dollar General (DG) Receives a Buy from Telsey Advisory

Telsey Advisory analyst Joe Feldman maintained a Hold rating on Dollar General today and set a price target of $140.00. According to TipRanks, Feld...

Telsey Advisory Keeps Their Hold Rating on Dollar General (DG)

The latest announcement is out from Quest Diagnostics ( ($DGX) ). At its May 20, 2026 annual meeting of stockholders, Quest Diagnostics shareholder...

Current Quarter	$2.81	Next Quarter	$2.8
Current Year	$10.72	Next Year	$11.57
QoQ Growth	-0.4%	YoY Growth	+7.9%
3Y EPS CAGR	+3.1%	Target Price	$223.00
Consensus	Buy	Upside	+14.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$195.00	-1.40%	1.29M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$195.00	-1.4%	1.29M
3
4
5
6

DGX

DGX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel